VIRTU-AS

  • Research type

    Research Study

  • Full title

    The (virtual) assessment of coronary blood flow before and after treatment of severe aortic stenosis.

  • IRAS ID

    301021

  • Contact name

    Julian Gunn

  • Contact email

    J.Gunn@Sheffield.ac.uk

  • Sponsor organisation

    Sheffield Teaching Hospitals NHS Foundation Trust

  • Duration of Study in the UK

    2 years, 6 months, 6 days

  • Research summary

    The aortic valve allows blood out of the heart. Patients with a narrowed valve (aortic stenosis, AS) can also develop narrowed arteries in the heart (coronary artery disease, CAD). It is hard to know whether to treat CAD in patients with AS, because AS can change the flow through the arteries, and treating the AS with a new valve (Transcatheter aortic valve implantation - TAVI) could reverse some of the changes. The accepted standards for treating CAD may therefore not apply in AS. We have developed a computer model of the circulation, and plan to adapt this to solve this problem. To do this, we will study patients who have AS and are being considered for treatment with TAVI. We will obtain data about their symptoms and quality of life with questionnaires, measure their activity levels with wearable technology and perform a simple walking test. The measurement of activity levels and questionnaires will be performed at the patients’ homes, the walk test at the pre-admission clinic, and the invasive procedures at the cardiac catheter laboratories of the Northern General Hospital, Sheffield. We will also perform a cardiac MRI before and after TAVI. We will then measure the blood flow down their coronary arteries using a tube in the circulation (this is a standard clinically approved method) before and after TAVI. We will repeat the questionnaires, activity monitoring, MRI and blood flow measurements some months later.
    This study is funded by the Heart Trust Charity Fund and Sheffield Hospitals Charity and will recruit 20 elective patients attending Sheffield Teaching Hospitals (STH) and referred to STH from District General Hospitals.

  • REC name

    North West - Preston Research Ethics Committee

  • REC reference

    22/NW/0017

  • Date of REC Opinion

    8 Feb 2022

  • REC opinion

    Favourable Opinion